Filing Flows › Biodesix (BDSX) › Development Services revenue
Biodesix (BDSX) Development Services revenue by quarter
Biodesix's Development Services revenue was $986K in Q3 2026 (third quarter 2026), -35% from Q2 2026. Over the last 7 quarters it ranged from $986K (Q3 2026) to $3.6M (Q4 2025).
| Quarter | Development Services revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $986K | -35% | -49% |
| Q2 2026 | $1.5M | -54% | -29% |
| Q1 2026 | $3.3M | -10% | +99% |
| Q4 2025 | $3.6M | +87% | — |
| Q3 2025 | $1.9M | -9% | — |
| Q2 2025 | $2.1M | +29% | — |
| Q1 2025 | $1.6M | — | — |
Q3 2026 at a glance
Biodesix, Q3 2026: revenue $24.0M (+10% year over year), operating margin -25.4%, net loss $8.0M, operating cash flow −$7.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Biodesix's Development Services revenue?
Biodesix's Development Services revenue was $986K in Q3 2026 (third quarter 2026), -35% from Q2 2026.
How has Biodesix's Development Services revenue changed?
Over the last 7 quarters it ranged from $986K (Q3 2026) to $3.6M (Q4 2025).